WATCH: PCCI leader shares insight on emerging technology and behavioral health
In this video interview from HIMSS24 with Jacqueline Naeem, MD, PCCI’s Senior Medical Director, shares with FinThrive her views on what new technology innovations are supporting mental health as well as what passions drive her as a physician.
To watch the video click here: https://studio.marketscale.com/StudioMail/dmJzaZ7KNPYV1el4RAwqG2NZqwV2ng905W6jopLyb3rDxX8O
In the News: Healthcare Innovation reports on PCCI and Parkland receiving a prestigious grant from Kaiser Permanented to help further their efforts to reduce the harm of pediatric asthma.
Continue reading
In the News: Healthcare Finance Features PCCI’s Dr. Naeem on Behavioral Health at HIMSS
Telehealth, wearables and artificial intelligence all hold promise to increase access to care for underserved populations.
To read the full story, click here:
https://www.healthcarefinancenews.com/news/technology-moving-needle-behavioral-health
In the News: D CEO Features PCCI’s Trauma Predictive Model
PCCI’s artificial intelligence is helping trauma surgery teams make data-based decisions about when to operate at Dallas County’s safety net hospital.
To read the full story, click here:
At Parkland Health, the End of Subjective Surgery – D Magazine
In the News: PCCI Data Scientist Talks With Healthcare IT News About Sepsis Prevention
Yusuf Tamer, PhD, principal data and applied scientist at the Parkland Center for Clinical Innovation, offers a sneak preview of his HIMSS24 session, which offers a detailed look at one of artificial intelligence’s most promising use cases.
To read the full story, click here:
https://www.healthcareitnews.com/news/how-ai-and-fhir-can-help-reduce-sepsis-mortality-rates
VIDEO: PCCI CEO, Steve Miff, Leads Invest Dallas-Fort Worth Launch Conference Panel
In this video from the recent Invest Dallas-Fort Worth Launch Conference, PCCI’s CEO Steve Miff, PhD, moderated a panel, “Closing the Gap: How educators and healthcare professionals collaborate to improve healthcare outcomes, the talent gap, and workforce wellbeing.” This important panel discussed providing more access to care, the importance of unbiased data, and strategies to improve healthcare outcomes.
PCCI Sachs Summer Scholar Makes Forbes 30 Under 30 List
In its recently released 30 Under 30 List, Forbes Magazine included Meghna “Chili” Pramoda in its Education section for her part in helping found SafeTeensOnline. Pramoda was a member of PCCI’s 2022 class of Sachs Summer Scholars interns, a program focused on advancing women in data science. During her term, Pramoda and a partner worked with PCCI data scientists for their research on using Safegraph Visualization in PCCI’s Community Vulnerability Compass. To view her and her partner’s end of term presentation, go to the 1 hour, 8 minute mark of this video: https://www.youtube.com/watch?v=d3BJ3EZJoE4
In the Forbes article on Pramoda, she is lauded for developing a system to support her peers in owning their online presence, from Forbes:
Founded by Vinny Veeramachaneni in 2017 and now spearheaded by cofounders Meghna “Chili” Pramoda and her sister Siona “Dolly” Pramoda, SafeTeensOnline is a nonprofit that offers English and Spanish language education on digital safety, in addition to courses in coding and ethical hacking. The Pramoda sisters created STOCyberReady, an app that helps teens understand the impact of their digital choices by analyzing their cyber risk and offering educational tips to reduce risk. The app is currently being used in 34 schools with a tentative public release set for 2024. SafeTeensOnline has partnered with the Taco Bell Foundation, T-Mobile, and the Department of Homeland Security.
Read the full article here: https://www.forbes.com/profile/safeteensonline/?sh=2a5c500913a5
PCCI Innovation – Pediatric Asthma AI/ML program receives Kaiser Permanente grant
The Kaiser Permanente Division of Research (KP-DOR) in partnership with the Gordon and Betty Moore Foundation has selected PCCI and Parkland Health’s AI/ML Model for Pediatric Asthma Care as one of five national programs to receive the prestigious award to advance Augmented Intelligence in Medicine and Healthcare (AIM-HI). The three-year grant is designed to evaluate the implementation of existing Artificial Intelligence/Machine Learning algorithms that enhance diagnostic decision-making, identify best practices for scalability, and build capacity for effectively implementing and rigorously evaluating the use of AI/ML algorithms in real-world settings. Through a rigorous and highly competitive process involving more than 120 leading organization pioneering AI in healthcare, the five organizations were selected representing a diverse set of diagnostic areas, patient populations and clinical settings.
“We are extremely proud and excited to be selected for the Augmented Intelligence in Medicine and Healthcare Initiative,” said PCCI’s CEO, Steve Miff, PhD. “This is one of the first and most comprehensive grants to date directly focusing on scaling and rigorously evaluating the ethical and equitable applications of AI in diagnostic decision-making in real-world settings. We are looking forward to not only contributing to advance the adoption of AI in patient care using sound research methods but learning from the industry leading experts at the Kaiser Permanente’s Division of Research and the pioneers in AI at the other AIM-HI peer organizations and their partners.”
PCCI and Parkland have developed and deployed an AI/ML risk prediction model leveraging EHR data to identify rising asthma risk in pediatric patients. The model generates risk reports to frontline providers and is integrated into Parkland’s EHR to trigger point-of-care alerts during outpatient visits for Very-High- or High-Risk patients. The programs also include a direct to patients and care-givers text-based engagement, education, symptom monitoring and alerting. Originally developed and deployed in collaboration with the Parkland Community Health Plan (PCHP) to support the care of Medicaid children across North Texas, the program was expanded to Parkland Health clinics in 2019 and has been highly effective in identifying rising risk patients and preventing ED and hospital admissions for asthma. (https://pccinnovation.org/parkland-program-helps-pediatric-patients-with-asthma-management/)
The AIM-HI program will test the generalizability of Parkland’s model in two additional large Federally Qualified Health Centers (FQHCs): Los Barrios Unidos (LBU) and Foremost Family Health Centers (Foremost), which serve some of the most underserved and diverse Dallas communities.
In addition to the organizations directly involved in the AIM-HI program, PCCI and Parkland Health continue to partner with Dallas County Health and Human Services (DCHHS) to expand the use of the new Pediatric Asthma Surveillance System (PASS) that describes community-level information regarding pediatric asthma risk factors in Dallas County. The PASS dashboard is available on the DCHHS website where families can be made aware of their local risks. (https://pccinnovation.org/new-site/pediatric-asthma-surveillance-system/)
Leading the program for PCCI include Yolande Pengetnze, MD, MS and George (Holt) Oliver, MD, PhD, with Parkland Health’s Cesar Termulo, Jr., MD, as the lead program investigator.
PCCI and Parkland have been innovators in building, deploying and testing AI/ML model for over a decade, with close to a dozen active model in production today. The pediatric asthma program supporting children with asthma in Dallas is one of these programs. To learn more about PCCI’s overall work, please view our newly released 2023 Impact Report.
For more information about the Kaiser Permanente AIM-HI program and learn about the other awardees go to: https://divisionofresearch.kaiserpermanente.org/kaiser-permanente-ai-machine-learning-in-health-care/
###
PCCI Recognition: D CEO includes PCCI in the 2024 Edition of the Dallas 500
For the fourth year in a row, PCCI’s CEO, Steve Miff, PhD, has been included in the DCEO #D500 list of top leaders in North Texas. The special edition of DCEO profiles the region’s most influential business, civic, and nonprofit leaders. This honor recognizes PCCI’s impactful mission to support the health of the most vulnerable in our communities.
Read more about this honor here: https://lnkd.in/gHamqvKK
Read Dr. Miff’s profile here: https://www.dmagazine.com/sponsored/2021/12/steve-miff-named-among-dallas-500-honorees/
PCCI fighting back against rising infant mortality rates
In this DCEO article, PCCI’s Yolande Pengetnze, MD, MS, FAAP, Vice President, Clinical Leadership, was quoted and PCCI (and its partners) were shown as leaders in helping support at-risk, pregnant women in the community – in the wake of new data released by the CDC. This article shows the real, positive impact of the preterm birth prevention program.
Read the article here: https://www.dmagazine.com/healthcare-business/2023/11/texas-is-one-of-four-states-with-increasing-infant-mortality-this-local-organization-is-fighting-back/
A highlight from the article:
Lack of health insurance and access to prenatal care is a significant factor for infant mortality, says Dr. Yolande Pengetnze, a pediatrician at the Parkland Center for Clinical Innovation. Other factors that increase infant mortality are social determinants of health, like transportation, healthy food, and childcare.
“When we see the data on infant mortality, an increase in mortality is driven by preterm delivery,” Pengetnze says. “It is mostly babies born at a gestational age of less than 24 weeks.”
PCCI has long been operating a program to target high-risk pregnant women to help them avoid preterm birth, the primary driver of infant mortality. The program helps them connect to prenatal care and overcome other barriers to seeing a provider. The Preterm Birth Intervention Program uses several factors to identify high-risk women signed up through the Parkland Community Health Program, a Medicaid managed care program. These women can sign up to receive text reminders to attend upcoming appointments and other educational interventions to prevent preterm births.